Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Mk0476 [montelukast] phase II dose finding study -allergic rhinitis-

Trial Profile

Mk0476 [montelukast] phase II dose finding study -allergic rhinitis-

Phase of Trial: Phase II

Latest Information Update: 24 Mar 2017

At a glance

  • Drugs Montelukast (Primary)
  • Indications Seasonal allergic rhinitis
  • Focus Therapeutic Use
  • Sponsors Merck & Co
  • Most Recent Events

    • 02 May 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top